Medical Device Studies Regulatory Requirements And Adverse Event Reporting Training Course Understanding MDR - Essential Course On New Regulations And Psurs (ONLINE EVENT: September 15-16, 2025)
Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Medical Device Studies: Regulatory Requirements and Adverse Event Reporting Training Course" training has been added to ResearchAndMarkets.com's offering.
This seminar provides an essential overview of medical device clinical evaluations, clinical investigations and PMCF studies with particular emphasis on the adverse event reporting requirements during these studies.
The course will concentrate mostly on the new Medical Device Regulations (MDR) with some references to the existing Medical Device Directives. It will provide a good introduction to medical device clinical studies and serve as an update for those with experience who need to keep abreast of the regulatory changes and the methods of handling adverse events during the study period. It also covers the new requirements regarding periodic safety update reports (PSURs) and the summary of safety and clinical performance.
Certification:
- CPD: 12 hours for your records Certificate of completion
Who Should Attend:
- Regulatory affairs specialists Quality assurance specialists Clinical research associates Junior clinical research associates Professionals involved in reporting adverse events during pre- and post-market clinical studies
Key Topics Covered:
Clinical evaluation - An overview
- What is a clinical evaluation? How do you conduct a clinical evaluation? The regulatory requirements pertaining to clinical evaluation
Clinical investigations - An overview
- What is a clinical investigation? When are clinical investigations needed? The regulatory requirements
PMS and PMCF
- What is PMS? What is PMCF? When are PMCF studies necessary?
Quiz on clinical evaluation, clinical investigation and PMCF
New requirements of the MDR
- Summary of safety and clinical performance Periodic safety update report (PSUR)
The competent authority and the Notified Body
- What is their role in the above processes? What are the responsibilities of the manufacturer? What to communicate and when
Workshop on the new requirements of the MDR
Vigilance reporting
- What is vigilance? The requirements for vigilance reporting during medical device studies
How to define and classify adverse events
- Definitions Types of events Determining categories
Vigilance workshop
The regulatory requirements for monitoring and reporting adverse events during regulatory and PMCF studies
- MEDDEV guidance document ISO 14155 harmonised standard Responsibilities Templates
The MDR - clinical elements
- Focus on changes in the clinical arena Chapter 6: clinical evaluation and investigation Annex 14: clinical evaluation and post-market clinical follow-up
For more information about this training visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Japan Buy Now Pay Later Market Size To Surpass USD 145.5 Billion By 2033 CAGR Of 22.23%
- BTCC Summer Festival 2025 Unites Japan's Web3 Community
- GCL Subsidiary, 2Game Digital, Partners With Kucoin Pay To Accept Secure Crypto Payments In Real Time
- Smart Indoor Gardens Market Growth: Size, Trends, And Forecast 20252033
- Nutritional Bar Market Size To Expand At A CAGR Of 3.5% During 2025-2033
- Pluscapital Advisor Empowers Traders To Master Global Markets Around The Clock
Comments
No comment